The Food Effect on PK Characteristics and Safety Profiles of PA-111
Phase 1
Not yet recruiting
- Conditions
- Mixed Dyslipidemia
- Interventions
- Drug: PA-111
- First Posted Date
- 2025-05-16
- Last Posted Date
- 2025-05-16
- Lead Sponsor
- Addpharma Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT06976489
- Locations
- 🇰🇷
H Plus Yangji Hospital, Seoul, Korea, Republic of
A Study to Compare to PK Characteristics and Safety Profiles Between PA-111 and PA-111A
Phase 1
Recruiting
- Conditions
- Mixed Dyslipidemia
- Interventions
- Drug: PA-111Drug: PA-111A
- First Posted Date
- 2025-04-17
- Last Posted Date
- 2025-04-17
- Lead Sponsor
- Addpharma Inc.
- Target Recruit Count
- 48
- Registration Number
- NCT06932705
- Locations
- 🇰🇷
H Plus Yangji Hospital, Seoul, Korea, Republic of
A Study to Compare PK/PD Characteristics and Safety Profiles Between AD-120 and AD-120A
Phase 1
Not yet recruiting
- Conditions
- Gastroesophageal Reflux Disease (GERD)
- Interventions
- Drug: AD-120ADrug: AD-120
- First Posted Date
- 2025-04-08
- Last Posted Date
- 2025-04-08
- Lead Sponsor
- Addpharma Inc.
- Target Recruit Count
- 48
- Registration Number
- NCT06916130
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of
The Study Compare and Evaluate the Safety and PK Data of a Single Dose Administration of 'AD-115A' or 'AD-1151'
Phase 1
Not yet recruiting
- Conditions
- Gastric Ulcer
- Interventions
- Drug: AD-115A, AD-1151
- First Posted Date
- 2025-03-30
- Last Posted Date
- 2025-03-30
- Lead Sponsor
- Addpharma Inc.
- Target Recruit Count
- 48
- Registration Number
- NCT06902818
A Study to Compare to PK Characteristics and Safety Profiles Between AD-227 and Co-administration of AD-227A and AD-227B
Phase 1
Recruiting
- Conditions
- Primary Hypertension
- Interventions
- Drug: Co-administration of AD-227A and AD-227BDrug: Administration of AD-227
- First Posted Date
- 2025-03-19
- Last Posted Date
- 2025-03-20
- Lead Sponsor
- Addpharma Inc.
- Target Recruit Count
- 60
- Registration Number
- NCT06884085
- Locations
- 🇰🇷
Central Hospital, Seoul, Korea, Republic of
A Study to Compare PK Characteristics and Safety Profiles Between AD-228B and AD-2284
Phase 1
Recruiting
- Conditions
- Primary Hypercholesterolaemia
- Interventions
- Drug: AD-228BDrug: AD-2284
- First Posted Date
- 2025-03-19
- Last Posted Date
- 2025-03-20
- Lead Sponsor
- Addpharma Inc.
- Target Recruit Count
- 60
- Registration Number
- NCT06884098
- Locations
- 🇰🇷
H Plus Yangji Hospital, Seoul, Korea, Republic of
A Study to Evaluate the Safety and Pharmacokinetics of AD-228A Compared to Coadministration of AD-2281 and AD-2282
Phase 1
Not yet recruiting
- Conditions
- Primary Hypercholesterolaemia
- Interventions
- Drug: AD-228ADrug: AD-2281 and AD-2282
- First Posted Date
- 2025-03-05
- Last Posted Date
- 2025-03-05
- Lead Sponsor
- Addpharma Inc.
- Target Recruit Count
- 60
- Registration Number
- NCT06858865
- Locations
- 🇰🇷
H+ Yangji Hospital, Seoul, Korea, Republic of
A Study to Evaluate the Efficacy and Safety of Co-administration of AD-2281 and AD-2282
Phase 3
Not yet recruiting
- Conditions
- Primary Hypercholesterolemia
- Interventions
- First Posted Date
- 2024-12-24
- Last Posted Date
- 2025-02-04
- Lead Sponsor
- Addpharma Inc.
- Target Recruit Count
- 110
- Registration Number
- NCT06747936
Phase 3 Study to Evaluate the Efficacy and Safety of Co-administrated AD-2021 and AD-2022
Phase 3
Completed
- Conditions
- Hypertension, EssentialPrimary Hypercholesterolemia
- Interventions
- First Posted Date
- 2024-06-07
- Last Posted Date
- 2024-06-07
- Lead Sponsor
- Addpharma Inc.
- Target Recruit Count
- 109
- Registration Number
- NCT06448962
- Locations
- 🇰🇷
Yonsei Cardiovascular Hospital, Seoul, Korea, Republic of
A Study to Evaluate the Efficacy and Safety of Co-administration of AD-227A and AD-227B
Phase 3
Recruiting
- Conditions
- Essential Hypertension
- Interventions
- First Posted Date
- 2024-06-04
- Last Posted Date
- 2025-02-04
- Lead Sponsor
- Addpharma Inc.
- Target Recruit Count
- 251
- Registration Number
- NCT06441630
- Locations
- 🇰🇷
Gangnam CHA Medical Center, Seoul, Korea, Republic of
© Copyright 2025. All Rights Reserved by MedPath